Stay updated on Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-07T19:06:24.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-04-30T13:46:43.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about various types of peripheral T-cell lymphomas and their treatment, while significant details about the clinical trial objectives and procedures have been removed.
    Difference
    57%
    Check dated 2025-04-16T01:38:16.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 23, 2025.
    Difference
    0.5%
    Check dated 2025-04-08T20:11:42.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.2%
    Check dated 2025-04-01T14:18:02.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-18T08:51:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pralatrexate in T-Cell Lymphomas Clinical Trial page.